Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

PHASE3CompletedINTERVENTIONAL
Enrollment

582

Participants

Timeline

Start Date

November 2, 2012

Primary Completion Date

February 5, 2015

Study Completion Date

December 17, 2021

Conditions
Non-Squamous Cell Non-small Cell Lung Cancer
Interventions
BIOLOGICAL

Nivolumab

DRUG

Docetaxel

Trial Locations (119)

0

Local Institution - 0043, Hong Kong

18

Local Institution - 0131, Miraflores

34

Local Institution - 0048, Lima

54

Local Institution - 0050, Arequipa

1130

Local Institution, Vienna

1426

Local Institution - 0010, Capital Federal

1431

Local Institution - 0057, Capital Federal

2485

Local Institution, Tweed Heads

3065

Local Institution, Melbourne

3199

Local Institution, Frankston

4020

Local Institution, Linz

4031

Local Institution, Basel

4102

Local Institution, Woolloongabba

4600

Local Institution, Wels

5000

Local Institution, Adelaide

5020

Local Institution, Salzburg

5037

Local Institution, Kurralta Park

5300

Local Institution - 0125, La Rioja

7000

Local Institution, Chur

10065

Local Institution - 0020, New York

11501

Local Institution - 0008, Mineola

13915

Local Institution - 0112, Marseille

14080

Local Institution - 0108, Mexico City

18840

Local Institution - 0035, Sayre

19047

St. Mary Medical Center, Langhorne

19111

Fox Chase Cancer Center, Philadelphia

20133

Local Institution - 0085, Milan

21079

Local Institution, Dijon

21287

The Johns Hopkins University, Baltimore

22927

Local Institution, Großhansdorf

24127

Local Institution - 0122, Bergamo

27710

Local Institution - 0027, Durham

28040

Local Institution, Madrid

28050

Local Institution, Madrid

29210

Local Institution - 0025, Columbia

30060

Northwest Georgia Oncology Center, P.C., Marietta

31300

Local Institution, Toulouse

33612

Local Institution - 0034, Tampa

35033

Local Institution - 0114, Rennes

35128

Local Institution - 0084, Padua

37203

Local Institution - 0028, Nashville

37232

Vanderbilt University Medical Center, Nashville

37404

Local Institution - 0024, Chattanooga

40138

Local Institution - 0086, Bologna

41013

Local Institution - 0001, Seville

43100

Local Institution - 0121, Parma

45242

Local Institution - 0026, Cincinnati

45657

Local Institution, Recklinghausen

47014

Local Institution - 0087, Meldola (fc)

48121

Local Institution - 0088, Ravenna

48903

Local Institution, Vizcaya

51109

Local Institution - 0090, Cologne

53100

Local Institution - 0082, Siena

55131

Local Institution, Mainz

60637

Local Institution - 0030, Chicago

64060

Local Institution, Monterrey

69126

Local Institution, Heidelberg

69373

Local Institution - 0113, Lyon

70376

Local Institution, Stuttgart

70891

Local Institution - 0067, Szczecin

75390

Local Institution - 0033, Dallas

77030

Local Institution - 0032, Houston

83280

Local Institution, Hermosillo

85259

Mayo Clinic Arizona, Scottsdale

85925

Local Institution - 0119, La Roche-sur-Yon

86000

Local Institution, Poitiers

89081

Local Institution, Ulm

91010

Local Institution - 0009, Duarte

92123

Local Institution - 0042, San Diego

94010

Local Institution, Créteil

94115

San Francisco Oncology Associates, San Francisco

98104

Swedish Cancer Institute, Seattle

98109

Local Institution - 0007, Seattle

99336

Local Institution - 0041, Kennewick

99437

Local Institution, Bad Berka

169610

Local Institution, Singapore

197022

Local Institution - 0080, Saint Petersburg

200385

Local Institution - 0063, Craiova

300167

Local Institution - 0062, Timișoara

308433

Local Institution, Singapore

400352

Local Institution - 0123, Cluj-Napoca

700106

Local Institution - 0061, Iași

7600448

Local Institution - 0058, Santiago

8420383

Local Institution - 0077, Santiago

60336550

Local Institution - 0056, Fortaleza

06520

Yale University, New Haven

02215

Local Institution - 0031, Boston

Local Institution - 0040, Boston

Local Institution - 0138, Boston

03756

Dartmouth-Hitchcock Medical Center, Lebanon

26506-9162

Local Institution - 0019, Morgantown

C1181ACH

Local Institution - 0124, Ciudad de Buenos Aires

C1280AEB

Local Institution - 0011, Buenos Aires

40170-110

Local Institution - 0054, Salvador

90020-090

Local Institution - 0053, Porto Alegre

90610-000

Local Institution - 0055, Porto Alegre

14784-400

Local Institution - 0052, Barretos

20231-050

Local Institution - 0051, Rio de Janeiro

T6G 1Z2

Local Institution - 0133, Edmonton

N6A 4L6

Local Institution, London

G5L 5T1

Local Institution - 0110, Rimouski

Unknown

Local Institution - 0012, Viña del Mar

Local Institution - 0134, Santiago

Local Institution, Hong Kong

180 81

Local Institution - 0018, Prague

H-1121

Local Institution - 0074, Budapest

06132

Local Institution - 0083, Perugia

06735

Local Institution - 0107, Mexico City

0424

Local Institution - 0141, Oslo

L-27

Local Institution - 0049, Lima

30-002

Local Institution - 0073, Krakow

80-19

Local Institution - 0068, Gdansk

10-513

Local Institution - 0072, Olsztyn

02-781

Local Institution - 0070, Warsaw

010976

Local Institution - 0099, Bucharest

115 478

Local Institution - 0078, Moscow

Local Institution - 0079, Moscow

Local Institution - 0120, Moscow

08035

Local Institution, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01673867 - Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC | Biotech Hunter | Biotech Hunter